Edgewise Therapeutics

Edgewise Therapeutics

Latest funding
$50,000,000
Venture capital (Series B) - 2019
New Leaf Venture Partners OrbiMed Advisors CureDuchenne Ventures +3
Team Size
1–10
Employees
$95,000,000 Venture capital (Series C)
Pulse 2.0

Biopharmaceutical Company Edgewise Therapeutics Closes $95 Million In Series C

$50,000,000 Venture capital (Series B)
FinSMEs

Edgewise Therapeutics Raises $50M in Series B Financing